BIO-PATH HOLDINGS INC
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| BIO-PATH HOLDINGS, INC. | ||
| Dated: March 7, 2024 | By: | /s/ Peter H. Nielsen |
|---|---|---|
| Peter H. Nielsen | ||
| President | ||
| Chief Executive Officer | ||
| Chief Financial Officer | ||
| Principal Accounting Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Date | Title | Signature | |||
|---|---|---|---|---|---|
| | | | | | |
| March 7, 2024 | | President/Chief Executive Officer/ Chief Financial Officer/ | | /s/ Peter H. Nielsen | |
| | | Principal Accounting Officer/Director | | Peter H. Nielsen | |
| | | | | | |
| March 7, 2024 | | Director | | /s/ Heath W. Cleaver | |
| | | | | Heath W. Cleaver | |
| | | | | | |
| March 7, 2024 | | Director | | /s/ Paul D. Aubert | |
| | | | | Paul D. Aubert | |
| | | | | | |
| March 7, 2024 | | Director | | /s/ Aline B. Sherwood | |
| | | | | Aline B. Sherwood | |
| | | | | | |
| March 7, 2024 | | Director | | /s/ Douglas P. Morris | |
| | | | | Douglas P. Morris | |
Index to Consolidated Financial Statements
| Bio-Path Holdings, Inc. Financial Statements | Page | ||
|---|---|---|---|
| Reports of Independent Registered Public Accounting Firms (PCAOB ID: 42) | | F-2 | |
| Consolidated Balance Sheets | | F-4 | |
| Consolidated Statements of Operations | | F-5 | |
| Consolidated Statements of Cash Flows | | F-6 | |
| Consolidated Statements of Shareholders’ Equity | | F-7 | |
| Notes to Consolidated Financial Statements | | F-8 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.